Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
funding
MedTech
Mainz Biomed looks to shed ColoAlert
Mainz Biomed inked a private deal for $6 million and is looking to shed its colorectal cancer assets as it shifts its focus to pancreatic cancer.
Joseph Keenan
Feb 20, 2026 7:50am
Santé Ventures closes $330M fund for biotech, medtech and more
Feb 2, 2026 8:15am
Novo foundation invests $860M to nurture homegrown biotechs
Jan 15, 2026 3:30am
Precision Neuroscience inks partnership with venture fund
Nov 5, 2025 9:00am
Hemab raises $157M series C for rare bleeding disorder goals
Oct 27, 2025 6:00am
Pelage locks in $120M series B for hair growth program
Oct 15, 2025 7:00am
